Technical Analysis for INVA - Innoviva, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
180 Bearish Setup | Bearish Swing Setup | 0.00% | |
Reversal New Lows Setup | Bearish Swing Setup | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Stochastic Buy Signal | Bullish | -2.02% | |
Pocket Pivot | Bullish Swing Setup | -2.02% | |
Volume Surge | Other | -2.02% | |
Outside Day | Range Expansion | -2.02% | |
Oversold Stochastic | Weakness | -2.02% | |
Cup with Handle | Other | -1.09% |
Alert | Time |
---|---|
Outside Day | about 16 hours ago |
Fell Below Previous Day's Low | about 16 hours ago |
Down 1% | about 16 hours ago |
60 Minute Opening Range Breakdown | about 17 hours ago |
10 DMA Resistance | about 17 hours ago |
Get a Trading Sidekick!
- Earnings date: 02/26/2024
Innoviva, Inc. Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Drugs Asthma Chronic Obstructive Pulmonary Disease Pulmonary Disease Glucocorticoids Antero Combination Drugs Corticosteroid Organofluorides Respiratory Products Fluticasone
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 16.865 |
52 Week Low | 10.96 |
Average Volume | 679,154 |
200-Day Moving Average | 14.05 |
50-Day Moving Average | 15.77 |
20-Day Moving Average | 15.15 |
10-Day Moving Average | 14.85 |
Average True Range | 0.38 |
RSI (14) | 31.97 |
ADX | 13.39 |
+DI | 17.87 |
-DI | 18.52 |
Chandelier Exit (Long, 3 ATRs) | 15.52 |
Chandelier Exit (Short, 3 ATRs) | 15.69 |
Upper Bollinger Bands | 15.83 |
Lower Bollinger Band | 14.46 |
Percent B (%b) | 0.07 |
BandWidth | 9.08 |
MACD Line | -0.29 |
MACD Signal Line | -0.26 |
MACD Histogram | -0.0304 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 15.22 | ||||
Resistance 3 (R3) | 15.29 | 15.14 | 15.11 | ||
Resistance 2 (R2) | 15.14 | 14.97 | 15.11 | 15.07 | |
Resistance 1 (R1) | 14.85 | 14.87 | 14.78 | 14.78 | 15.04 |
Pivot Point | 14.70 | 14.70 | 14.66 | 14.67 | 14.70 |
Support 1 (S1) | 14.41 | 14.53 | 14.34 | 14.34 | 14.08 |
Support 2 (S2) | 14.26 | 14.43 | 14.23 | 14.05 | |
Support 3 (S3) | 13.97 | 14.26 | 14.01 | ||
Support 4 (S4) | 13.90 |